Partsch G, Schwarzer C, Dunky A, Mayer F, Gschnait F, Neumüller J, Eberl R
Z Rheumatol. 1985 Nov-Dec;44(6):267-9.
By means of radio-immunoassay the concentration of human growth hormone (HGH) was measured in the blood plasma of 61 patients with psoriasis (21 suffering from psoriasis vulgaris and 40 with psoriatic arthritis), 30 patients with ankylosing spondylitis, 9 with atypical spondylarthritis and 34 patients with diseases of the soft tissue or degenerative joint and spinal column disease. No connection was found between the HGH concentration and the skin lesions in psoriasis. On the other hand a correlation between HGH and the sacroiliitis in psoriatic arthritis and seronegative spondyloarthropathies may be possible. In contrast to the plasma of psoriatics, the mean HGH concentration was higher in the plasma of patients with degenerative joint diseases. Therefore the results of this paper confirm those opinions in the literature which deny increased HGH concentrations in psoriatics. The beneficial effect of the therapeutic administration of somatostatin, an inhibitor of the release of HGH, in psoriasis vulgaris and psoriatic arthritis is - if indeed it occurs - attributable to other hitherto unidentified mechanisms.
通过放射免疫分析法,对61例银屑病患者(21例寻常型银屑病患者和40例银屑病关节炎患者)、30例强直性脊柱炎患者、9例非典型脊柱关节炎患者以及34例软组织疾病或退行性关节和脊柱疾病患者的血浆中人生长激素(HGH)浓度进行了测量。未发现HGH浓度与银屑病皮肤病变之间存在关联。另一方面,HGH与银屑病关节炎和血清阴性脊柱关节病中的骶髂关节炎之间可能存在相关性。与银屑病患者的血浆相比,退行性关节疾病患者血浆中的平均HGH浓度更高。因此,本文的结果证实了文献中那些否认银屑病患者HGH浓度升高的观点。生长抑素是HGH释放的抑制剂,其治疗性给药在寻常型银屑病和银屑病关节炎中若确实有有益效果,则归因于其他迄今尚未明确的机制。